Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q4 FY24 results · Jan–Mar 2024
Acutaas Chemicals reported revenue from operations of ₹224.96 crore (up 20.7% from Q4 FY23) and net profit of ₹25.68 crore (down 5.6% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 224.96 | 186.38 | +20.7% | 166.44 | +35.2% |
| Other income | 1.34 | (0.17) | Turned profit | 3.49 | −61.5% |
| Total income | 226.30 | 186.21 | +21.5% | 169.94 | +33.2% |
| Profit before tax | 37.20 | 36.66 | +1.5% | 23.70 | +57.0% |
| Net profit for the period | 25.68 | 27.20 | −5.6% | 17.81 | +44.2% |
| Attributable to shareholders of the company | 25.15 | — | — | 16.75 | +50.1% |
| EPS, basic (₹) | 6.86 | 7.46 | −8.1% | 4.83 | +42.0% |
| Net margin (%) | 11.4 | 14.6 | 10.7 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 219.94 | 186.38 | +18.0% | 161.70 | +36.0% |
| Other income | 8.55 | (0.17) | Turned profit | 2.87 | +198.0% |
| Total income | 228.49 | 186.21 | +22.7% | 164.57 | +38.8% |
| Profit before tax | 42.29 | 36.62 | +15.5% | 20.34 | +107.9% |
| Net profit for the period | 32.08 | 27.16 | +18.1% | 15.70 | +104.3% |
| EPS, basic (₹) | 8.75 | 7.45 | +17.4% | 4.26 | +105.4% |
| Net margin (%) | 14.6 | 14.6 | 9.7 |
Consolidated
- Filed with BSE
- 13 May 2024, 10:20 IST
- Board meeting
- 10 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 May 2024, 10:20 IST
- Board meeting
- 10 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE